• Publications
  • Influence
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
Treatment with aspirin and ticlopidine after coronary stenting resulted in a lower rate of stent thrombosis, although there were more hemorrhagic complications than with aspirin alone.
Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts
Use of this distal protection device during stenting of stenotic venous grafts was associated with a highly significant reduction in major adverse events compared with stenting over a conventional angioplasty guidewire, demonstrating the importance of distal embolization in causing major adverse cardiac events and the value of embolic protection devices in preventing such complications.
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
This dissertation aims to provide a history of earthquake-triggered landsliding in Japan from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year of the tsunami of 1997.
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.
The no-reflow phenomenon--reduction in distal flow without apparent dissection or distal embolization--occurs in 2% of coronary interventions and generally responds promptly to intracoronary verapamil administration, suggesting that distal microvascular spasm may be its etiology.
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions)
Implantation of sirolimus-eluting stents compared with bare metal stents in de novo coronary lesions reduces major adverse cardiac events in patients with and without diabetes mellitus, but there remains a trend toward a higher frequency of repeat intervention in diabetic patients compared with nondiabetic patients, particularly in the insulin-requiring patients.
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
This study compared the efficacy and safety of three antithrombotic-drug regimens — aspirin alone, aspirin and warfarin, and aspirin and ticlopidine — after coronary stenting to prevent stent thrombosis.
Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
BackgroundThere are limited studies of stent thrombosis in the modern era of second-generation stents, high-pressure deployment, and current antithrombotic regimens. Methods and ResultsSix recently
Current complications of diagnostic and therapeutic cardiac catheterization.
The complication rates for diagnostic catheterization compare favorably with those of previous multicenter registries, but current overall complication rates are significantly higher because of the performance of therapeutic procedures with greater intrinsic risk and the inclusion of increasingly aged and acutely ill or unstable patients.
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
At one year after stenting, most clinical restenosis reflected TLR, which was predicted by the same variables previously associated with an increased risk of angiographic restenotic.